Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > REMEMBER when AGpicks (eg pumper) liked lexx?

<< Previous

Bullboard Posts

Next >>

Comment by DehydraTECHon Jun 21, 2022 5:49pm

95 Views

Post# 34772455

RE:RE:RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

Another great press to scale across USA

DehydraTECH wrote: Wakeup you think this company a scam It's clear you have no idea how biotechs investments need plenty of Data inputs to get real licensing deals in place Fwiw do you also know it takes a B2B 6months to 1 year of own due diligence if the dehydratech will work with any new products they are looking to introduce.. Premier cosmetics seems to have come out of left field with huge revenue potential Looks like the short game is over and all longs have dollar cost averaged on this potential dividend investment opportunity say 2 years out I'm willing to bet with the last 3 deals signed in all high margin markets will bring more players bringing royalties above 10 million yearly This doesn't even include Altria investigating our new buccal DehydraTECH vs in the GI tract as initially proven Last but not least FDA IND FAST APPROACHING Potential big pharma partners will all be bidding to compete against the only CBD fda approved DRUG whom JAZZ purchased for 7 billion I'd say LEXX was manipulated and diick head shorts didn't see the latest deals with more exposure coming to DehydraTECH globally This is and easy 10x to 150 million value
WakeUPP wrote: hey ranman do you not know who i am yet?

Do you remember totally hip software? I made the news in stockwatch several times, before the CEO was fired, and the stock failed. too bad you cant go back to see what I said there, or know wha tthe CEO TRIED to do to me

the stockwatch reporter knew me as I outed the KRY scammers for what was going on

the chief knew me VERY WELL (on stockhouse lol) as I outed the many scams he pumped, ESPECIALLY the interent radio one

ME, outing scams for over 20 YEARS

oh, who was I on SI...

HERE IS THE TIP: READ, READ, READ the financials, NOT stock promo. MOST are going to zero!!!